Punarnava (Boerhavia diffusa)
TL;DR
Punarnava (Boerhavia diffusa) is a traditional Ayurvedic herb used for swelling, urinary problems, and as a rejuvenative. Modern evidence is almost entirely from animal and laboratory studies, with one old, small controlled trial in nephrotic syndrome. There is no reliable human evidence for treating kidney, liver, or heart disease. (51 words)
What it is
Punarnava (Boerhavia diffusa) is a perennial, prostrate (spreading) herb of the Nyctaginaceae family, found across India and other tropical regions. Its name means "that which renews": the plant is said to revive after the dry season. The root and whole plant are used in Ayurvedic preparations, including fresh juice, decoctions, and powders (Das et al., 2023).
Traditional use
In Ayurveda, punarnava is classed as a rasayana (rejuvenative) herb. Its best-known traditional role is as a diuretic, promoting urine flow, and it has long been used for edema (swelling), ascites (abdominal fluid accumulation), urinary and kidney complaints, and liver disorders. Traditional texts also describe it as supporting vitality and healthy aging. These are historical and practitioner-reported uses, and they should not be read as evidence that the herb treats these conditions (Das et al., 2023).
What modern research says
The honest summary is that modern human evidence is nearly absent.
State-of-the-art review (2023)
A comprehensive 2023 review surveyed the full body of punarnava research: botany, phytochemistry, and pharmacology. It found that the vast majority of modern evidence comes from animal studies, isolated-tissue (ex vivo) experiments, cell cultures, and computer modeling: not from people. The review catalogues diuretic, anti-inflammatory, hepatoprotective, and nephroprotective activity in laboratory and animal models, but none of this establishes that punarnava works in human patients (Das et al., 2023).
One old preliminary controlled trial
The review reports a small number of human studies: a preliminary controlled 1972 trial in nephrotic syndrome (Singh and Udupa, Journal of Research in Indian Medicine), a controlled trial of BD extract as a chemotherapy adjuvant in 50 pulmonary-tuberculosis patients (Kant et al., 2001), and a two-group six-month trial in diabetic nephropathy (Singh et al., 2010). The full methods of the 1972 study are not accessible in modern databases, and none of these studies has been replicated with contemporary methods. They cannot support treatment claims today; at most, they show researchers considered the herb worth testing (Das et al., 2023).
Bottom line on the evidence
There is currently no high-quality, modern, placebo-controlled human evidence that punarnava treats edema, kidney disease, nephrotic syndrome, liver disease, heart failure, or any other condition. Marketing claims that go beyond the traditional uses described above are not backed by human data.
Dosage
No established dose exists. No pharmacopoeial monograph or clinical trial with a clearly reported, verifiable dose was identified in this review. Traditional preparations include fresh plant juice, decoctions, and powders in varying amounts, but traditional dosing is not the same as a tested safe and effective dose. Anyone considering punarnava should discuss it with a qualified clinician rather than following informal dosage advice.
Safety & contraindications
- Evidence gap is itself the main safety issue. Because human studies are so limited, the safety profile of punarnava, especially at medicinal doses and with prolonged use, is poorly characterized.
- Kidney, heart, or liver disease: if the herb has diuretic activity, as traditionally claimed, it could affect fluid and electrolyte balance. People with kidney, heart, or liver conditions, and anyone taking diuretics, blood-pressure medicines, or drugs that affect electrolytes (such as potassium), should not use punarnava without clinician oversight.
- Pregnancy and breastfeeding: safety data are insufficient; avoid medicinal use without clinical advice.
- Not a substitute for medical care. Edema and urinary symptoms can signal serious disease. Punarnava is not a proven treatment for kidney disease, liver disease, or heart failure and must never replace prescribed treatment.
FAQs
What is punarnava used for in Ayurveda?
It is traditionally used as a diuretic and rejuvenative herb for swelling, urinary and kidney complaints, and liver disorders. These are traditional uses, not proven medical effects.
Is there human evidence that punarnava helps kidney disease?
No reliable modern evidence. Human studies are limited to small, old trials, a preliminary 1972 nephrotic-syndrome trial, a 2001 tuberculosis-adjuvant trial, and a 2010 diabetic-nephropathy trial, whose details are not fully accessible today, and none has been replicated with modern methods.
Can punarnava replace my water pill (diuretic)?
No. There is no human evidence that punarnava works as a diuretic medicine, and unmonitored use could be risky for people with kidney, heart, or liver disease.
Is punarnava safe in pregnancy?
Safety in pregnancy and breastfeeding has not been established. Avoid medicinal use without clinical advice.
What is the correct dose of punarnava?
There is no established dose. No clinical trial or pharmacopoeial monograph with a verified dose was identified.
Sources
Related herbs
Disclaimer
This article is for informational purposes only and is not medical advice. Punarnava is not a proven treatment for kidney, liver, or heart disease and must never replace prescribed treatment. If you have a medical condition, take prescription medicines, are pregnant or breastfeeding, or are considering any supplement, talk to a qualified clinician first.